190 related articles for article (PubMed ID: 12571200)
21. Risk stratification of patients after myocardial revascularization by stress Tc-99m tetrofosmin myocardial perfusion tomography.
Elhendy A; Schinkel AF; van Domburg RT; Bax JJ; Valkema R; Poldermans D
J Nucl Cardiol; 2003; 10(6):615-22. PubMed ID: 14668773
[TBL] [Abstract][Full Text] [Related]
22. Association of ischemia on stress (99m)Tc-tetrofosmin myocardial perfusion imaging with all-cause mortality in patients with diabetes mellitus.
Elhendy A; Huurman A; Schinkel AF; Bax JJ; van Domburg RT; Valkema R; Biagini E; Poldermans D
J Nucl Med; 2005 Oct; 46(10):1589-95. PubMed ID: 16204707
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of normal exercise 99mTc-sestamibi myocardial tomography in patients with angiographic coronary artery disease.
Yang MF; Dou KF; Liu XJ; Yang YJ; He ZX
Nucl Med Commun; 2006 Apr; 27(4):333-8. PubMed ID: 16531918
[TBL] [Abstract][Full Text] [Related]
24. Cardiovascular disease risk stratification with stress single-photon emission computed tomography technetium-99m tetrofosmin imaging in patients with the metabolic syndrome and diabetes mellitus.
Shaw LJ; Berman DS; Hendel RC; Alazraki N; Krawczynska E; Borges-Neto S; Maddahi J; Cerqueira M
Am J Cardiol; 2006 May; 97(10):1538-44. PubMed ID: 16679101
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of stress dobutamine technetium-99m sestamibi single-photon emission computed tomography (SPECT) in patients with suspected coronary artery disease.
Senior R; Raval U; Lahiri A
Am J Cardiol; 1996 Nov; 78(10):1092-6. PubMed ID: 8914869
[TBL] [Abstract][Full Text] [Related]
26. Incremental prognostic value of myocardial SPET with dual-isotope rest (201)Tl/stress (99m)Tc-tetrofosmin.
Groutars RG; Verzijlbergen JF; Zwinderman AH; Tiel-Van Buul MM; Ascoop CA; van Hemel NM; van der Wall EE
Eur J Nucl Med Mol Imaging; 2002 Jan; 29(1):46-52. PubMed ID: 11807606
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of exercise stress technetium-99m-tetrofosmin myocardial perfusion imaging in patients with normal baseline electrocardiograms.
Elhendy A; Schinkel AF; van Domburg RT; Bax JJ; Valkema R; Huurman A; Feringa HH; Poldermans D
Am J Cardiol; 2006 Sep; 98(5):585-90. PubMed ID: 16923441
[TBL] [Abstract][Full Text] [Related]
28. Incremental prognostic value of myocardial perfusion 99m-technetium-sestamibi SPECT in the elderly.
Lima RS; De Lorenzo A; Pantoja MR; Siqueira A
Int J Cardiol; 2004 Feb; 93(2-3):137-43. PubMed ID: 14975539
[TBL] [Abstract][Full Text] [Related]
29. Eleven-year prognostic value of dobutamine stress (99m)Tc-sestamibi myocardial perfusion imaging in patients with limited exercise capacity.
Boiten HJ; van Domburg RT; Valkema R; Schinkel AF
Am J Cardiol; 2015 Apr; 115(7):884-9. PubMed ID: 25661571
[TBL] [Abstract][Full Text] [Related]
30. Prediction of mortality in patients with coronary artery disease undergoing vasodilator stress testing: a comparison between 99mTc-tetrofosmin and 99mTc-sestamibi.
Adams GL; Shaw LK; Tuttle RH; Hanson MW; Pagnanelli R; Borges-Neto S
Nucl Med Commun; 2007 Jun; 28(6):457-63. PubMed ID: 17460536
[TBL] [Abstract][Full Text] [Related]
31. Prognostic implications of stress Tc-99m tetrofosmin myocardial perfusion imaging in patients with left ventricular hypertrophy.
Elhendy A; Schinkel AF; van Domburg RT; Bax JJ; Feringa HH; Noordzij PG; Schouten O; Poldermans D
J Nucl Cardiol; 2007 Jul; 14(4):550-4. PubMed ID: 17679064
[TBL] [Abstract][Full Text] [Related]
32. Prediction of 8-year cardiovascular outcomes in patients with systemic arterial hypertension: value of stress (99m)Tc-tetrofosmin myocardial perfusion imaging in a high-risk cohort.
Wai MC; Ottenhof MJ; Boiten HJ; Valkema R; van Domburg RT; Schinkel AF
J Nucl Cardiol; 2013 Dec; 20(6):1030-40. PubMed ID: 24132813
[TBL] [Abstract][Full Text] [Related]
33. Survival by stress modality in patients with a normal myocardial perfusion study.
Johnson NP; Schimmel DR; Dyer SP; Leonard SM; Holly TA
Am J Cardiol; 2011 Apr; 107(7):986-9. PubMed ID: 21256467
[TBL] [Abstract][Full Text] [Related]
34. Technetium-99m-tetrofosmin in dipyridamole-stress myocardial SPECT imaging: intraindividual comparison with technetium-99m-sestamibi.
Flamen P; Bossuyt A; Franken PR
J Nucl Med; 1995 Nov; 36(11):2009-15. PubMed ID: 7472590
[TBL] [Abstract][Full Text] [Related]
35. Assessing coronary artery disease with dipyridamole technetium-99m-tetrofosmin SPECT: a multicenter trial.
He ZX; Iskandrian AS; Gupta NC; Verani MS
J Nucl Med; 1997 Jan; 38(1):44-8. PubMed ID: 8998148
[TBL] [Abstract][Full Text] [Related]
36. The value of 99mTc-tetrofosmin brain SPECT in predicting survival in patients with glioblastoma multiforme.
Alexiou GA; Tsiouris S; Kyritsis AP; Fotakopoulos G; Goussia A; Voulgaris S; Fotopoulos AD
J Nucl Med; 2010 Dec; 51(12):1923-6. PubMed ID: 21078797
[TBL] [Abstract][Full Text] [Related]
37. Gated (99m)Tc-tetrofosmin SPECT for discriminating infarct from artifact in fixed myocardial perfusion defects.
Fleischmann S; Koepfli P; Namdar M; Wyss CA; Jenni R; Kaufmann PA
J Nucl Med; 2004 May; 45(5):754-9. PubMed ID: 15136622
[TBL] [Abstract][Full Text] [Related]
38. Radiation dose and prognosis of ultra-low-dose stress-first myocardial perfusion SPECT in patients with chest pain using a high-efficiency camera.
Einstein AJ; Johnson LL; DeLuca AJ; Kontak AC; Groves DW; Stant J; Pozniakoff T; Cheng B; Rabbani LE; Bokhari S
J Nucl Med; 2015 Apr; 56(4):545-51. PubMed ID: 25745089
[TBL] [Abstract][Full Text] [Related]
39. Infarct size determination by technetium 99m sestamibi single-photon emission computed tomography predicts survival in patients with chronic coronary artery disease.
Hurrell DG; Milavetz J; Hodge DO; Gibbons RJ
Am Heart J; 2000 Jul; 140(1):61-6. PubMed ID: 10874264
[TBL] [Abstract][Full Text] [Related]
40. Long-term prognostic value of dobutamine stress echocardiography compared with myocardial perfusion scanning in patients unable to perform exercise tests.
Schinkel AF; Bax JJ; Elhendy A; van Domburg RT; Valkema R; Vourvouri E; Bountioukos M; Rizzello V; Biagini E; Agricola E; Krenning EP; Simoons ML; Poldermans D
Am J Med; 2004 Jul; 117(1):1-9. PubMed ID: 15210381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
